End-of-day quote
Taipei Exchange
06:00:00 2024-05-27 pm EDT
|
5-day change
|
1st Jan Change
|
173.5
TWD
|
-0.57%
|
|
-1.98%
|
-8.44%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
720.6
|
1,669
|
1,018
|
1,060
|
944.4
|
-
|
Enterprise Value (EV)
1 |
720.6
|
1,669
|
1,018
|
1,060
|
944.4
|
944.4
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
-
|
Yield
|
3.78%
|
2.78%
|
4.87%
|
-
|
6.32%
|
7.06%
|
Capitalization / Revenue
|
5.82
x
|
11.7
x
|
6.07
x
|
6.23
x
|
4.56
x
|
4.03
x
|
EV / Revenue
|
5.82
x
|
11.7
x
|
6.07
x
|
6.23
x
|
4.56
x
|
4.03
x
|
EV / EBITDA
|
-
|
22
x
|
15.6
x
|
17.9
x
|
10.8
x
|
9.92
x
|
EV / FCF
|
-
|
56,092,243
x
|
22,194,618
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
0%
|
0%
|
-
|
-
|
-
|
Price to Book
|
4.31
x
|
-
|
3.65
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
22,000
|
24,189
|
24,189
|
24,189
|
24,189
|
-
|
Reference price
2 |
32.76
|
68.98
|
42.08
|
43.84
|
39.04
|
39.04
|
Announcement Date
|
3/25/21
|
3/25/22
|
3/31/23
|
3/15/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
123.8
|
143
|
167.6
|
170.3
|
207.2
|
234.4
|
EBITDA
1 |
-
|
75.9
|
65.12
|
59.2
|
87.38
|
95.24
|
EBIT
1 |
34.42
|
49.83
|
55.88
|
47.4
|
68.86
|
77.78
|
Operating Margin
|
27.8%
|
34.84%
|
33.35%
|
27.83%
|
33.23%
|
33.19%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
29.75
|
45.86
|
-
|
-
|
-
|
FCF margin
|
-
|
20.8%
|
27.36%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
39.2%
|
70.42%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.239
|
1.918
|
2.048
|
-
|
2.468
|
2.757
|
Announcement Date
|
3/25/21
|
3/25/22
|
3/31/23
|
3/15/24
|
-
|
-
|
Fiscal Period: December |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
---|
Net sales
1 |
-
|
49.62
|
35.42
|
44.16
|
35.64
|
52.82
|
36.38
|
42.5
|
46.31
|
61.18
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
20.16
|
6.678
|
14.5
|
6.216
|
19.85
|
6.417
|
8.624
|
8.216
|
-
|
Operating Margin
|
-
|
40.63%
|
18.85%
|
32.83%
|
17.44%
|
37.57%
|
17.64%
|
20.29%
|
17.74%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
14.48
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.5982
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/11/22
|
11/11/22
|
3/31/23
|
5/15/23
|
8/9/23
|
11/10/23
|
3/15/24
|
5/14/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
29.7
|
45.9
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
21.1%
|
-
|
22.5%
|
23.4%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
18.2%
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
7.610
|
-
|
11.50
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
15.5
|
16.5
|
-
|
-
|
-
|
Capex / Sales
|
-
|
10.82%
|
9.87%
|
-
|
-
|
-
|
Announcement Date
|
3/25/21
|
3/25/22
|
3/31/23
|
3/15/24
|
-
|
-
|
Last Close Price
39.04
CNY Average target price
51.43
CNY Spread / Average Target +31.71% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.44% | 130M | | +21.97% | 43.89B | | -3.10% | 18.22B | | -20.15% | 2.23B | | +21.56% | 2.04B | | +18.16% | 1.13B | | -38.08% | 718M | | -7.94% | 671M | | -44.83% | 646M | | +44.48% | 554M |
Glasses, Spectacles & Contact Lenses
|